New York, Nov. 29 - Visiomed Group Ltd. said it has started a A$1.8 million offering of common stock.
The company will sell 90 million shares at A$0.02 each.
eG Capital Pty. Ltd. is advising Visiomed, which will release a prospectus shortly.
Net proceeds of A$1.6 million will be used for working capital, primarily to expand distribution of the company's Funhaler asthma space in the United States and Europe.
Visiomed is a Perth, Australia, medical device company.
| Issuer: | Visiomed Group Ltd.
|
| Issue: | Shares
|
| Amount: | A$1.8 million
|
| Shares: | 90 million
|
| Price: | A$0.02
|
| Announcement date: | Nov. 29
|
| Stock price: | A$0.023 at close Nov. 29
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
